Search
Close this search box.
Search
Subscriber Log In

Evaluate and Galen Growth Partner to Bring HealthTech Alpha’s Leading Digital Health Data and Insights to Market

London, UK – 28 September, 2023 – Evaluate, a leading provider of life sciences data and insights, and Galen Growth, the global leader in Digital Health data, intel and insights, today announced a commercial partnership to bring HealthTech Alpha to a broader market.

HealthTech Alpha is the number one choice for Digital Health insights for leading pharmaceutical, medical devices, insurers, business consultants, financial services, amongst many others. The platform provides the most comprehensive view of the Digital Health market, including market trends, competitive landscape, and insights into emerging technologies.

Under the terms of the partnership, Evaluate, a Norstella company, will be the exclusive reseller of HealthTech Alpha across the globe. The partnership will enable Evaluate to offer its customers a full range of healthcare data and insights and help them make better pipeline and portfolio decisions.

“Digital Health is a hugely important, fast-moving and innovative area of the healthcare space,” said Mike Gallup, CEO at Norstella. “The partnership with Galen Growth will enable our clients to add a critical digital component to the in-depth biopharma and medtech insights within our solutions. The addition of a digital lens on the market will support Norstella’s mission of smoothing the path to therapy from pipeline to patient.”

“We are delighted to partner with Evaluate,” said Julien de Salaberry, CEO and founder of Galen Growth. “Evaluate is a highly respected leader in the healthcare data and insights market, and we believe this partnership will help us accelerate the growth of HealthTech Alpha. We look forward to working together to bring this valuable resource to market.”

Members of the Evaluate and Galen Growth team will be attending HLTH 2023 in Las Vegas from 8-11 October.

About Galen Growth

Galen Growth is the global leader in Digital Health data, intel and insights. The company provides the most comprehensive view of the Digital Health market, including market trends, competitive landscape, and insights into emerging technologies. Galen Growth’s customers include leading pharmaceutical companies, medical device manufacturers, insurers, and institutional investors. For more information, visit Galen Growth and follow us on LinkedIn and Twitter.

Share

Press Inquiries

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip.

Latest Press Releases